cbdMD to acquire Twinlab supplement brands for $30M revenue boost

Charlotte, North Carolina - cbdMD, Inc., a publicly traded company, has announced its plans to acquire Twinlab, a well-established supplement brand, for a revenue boost of approximately $30 million. The acquisition, which includes Twinlab, Reserveage, Metabolife, and Alvita Tea, will be conducted through an assignment for the benefit of creditors and requires court approval.

Based on unaudited financial data, the combined revenue of the two companies for the trailing twelve months ending June 2026 is projected to be around $30 million, representing a 40% increase compared to cbdMD's standalone revenue. This acquisition is expected to reduce cbdMD's revenue concentration in the hemp category and diversify its product portfolio into daily wellness, active lifestyle, weight management, longevity, recovery, beauty, and functional supplementation categories.

Twinlab, a brand with a heritage dating back to 1968, operates in the supplements and sports nutrition industry, and its distribution channels, including major retailers like Vitamin Shoppe and GNC, as well as an Amazon presence, will be a valuable addition to cbdMD's existing operations.